Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RNPA1000 is an attractive antimicrobial development candidate and RnpA inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | 6-8 weeks | $ 732.00 | |
100 mg | 6-8 weeks | $ 1,090.00 |
Description | RNPA1000 is an attractive antimicrobial development candidate and RnpA inhibitor. |
In vitro | RnpA inhibitor The antibiotic vancomycin and a novel Staphylococcus aureus RnpA inhibitor under pre-clinical development, RNPA1000, were included in these studies. Longer incubations allowed for Staphylococcus aureus colonies to form near the vancomycin-infused cement, indicating that vancomycin may not be suitable for long-term biofilm inhibition in comparison to RNPA1000. Loading glass polyalkenoate cement with either 20-30% RNPA1000 or vancomycin prevented bacterial growth. |
Molecular Weight | 464.31 |
Formula | C23H18BrN3O3 |
CAS No. | 359600-10-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RNPA1000 359600-10-5 Others RNPA 1000 RNPA-1000 inhibitor inhibit